Guardian Pharmacy (GRDN) director gets 4,028 restricted share units

Rhea-AI Filing Summary

Guardian Pharmacy Services director LEWIS RANDALL J received an equity grant of 4,028 shares of Class A common stock on May 5, 2026. The award is structured as restricted stock units payable solely in shares of Class A common stock and carries no cash exercise price.

After this grant, the director holds 15,071 shares directly. This is a compensation-related award rather than an open-market purchase or sale, so it reflects routine equity-based compensation rather than a trading decision.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider LEWIS RANDALL J

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	4,028	$0.00	--

Holdings After Transaction: Class A Common Stock — 15,071 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Equity grant: 4,028 shares Price per share: $0.00 Holdings after transaction: 15,071 shares

3 metrics

Equity grant 4,028 shares Restricted stock units of Class A common stock granted May 5, 2026

Price per share $0.00 Reported transaction price for the restricted stock unit grant

Holdings after transaction 15,071 shares Director’s direct ownership of Class A common stock after grant

Key Terms

restricted stock units, Class A Common Stock, Grant, award, or other acquisition

3 terms

restricted stock units financial

"Represents restricted stock units payable solely in shares of Class A common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"security_title: Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LEWIS RANDALL J

(Last) (First) (Middle)

300 GALLERIA PARKWAY SE, SUITE 800

(Street)

ATLANTA GEORGIA 30339

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	05/05/2026		A		4,028(1)	A	$0.00	15,071	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units payable solely in shares of Class A common stock of the Issuer.

	/s/ Douglas Towns, Attorney-in-Fact	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Guardian Pharmacy (GRDN) disclose in this Form 4 filing?

Guardian Pharmacy reported that director LEWIS RANDALL J received 4,028 restricted stock units of Class A common stock on May 5, 2026. These units are equity compensation and do not involve a cash purchase or sale in the open market.

How many Guardian Pharmacy (GRDN) shares did the director acquire?

The director acquired 4,028 shares of Class A common stock through a grant classified as restricted stock units. This is a stock-based compensation award, not an open-market transaction, and increases the director’s direct holdings reported in the filing.

What are restricted stock units in the Guardian Pharmacy (GRDN) Form 4?

The filing describes the award as restricted stock units payable solely in shares of Class A common stock. These units represent a right to receive shares, typically subject to vesting or service conditions, rather than an immediate unrestricted share issuance.

What is the director’s ownership in Guardian Pharmacy (GRDN) after the grant?

Following the grant of 4,028 restricted stock units, the director’s total direct holdings reported in the Form 4 are 15,071 shares of Class A common stock. This figure reflects ownership after the reported compensation transaction on May 5, 2026.

Was cash paid for the Guardian Pharmacy (GRDN) shares in this Form 4?

No cash changed hands in this transaction, as the reported price per share is zero. The 4,028 shares were awarded as restricted stock units, indicating stock-based compensation instead of an open-market buy or sell for cash consideration.